Surmodics Inc (SRDX)

May 02, 2025

Are Options Traders Betting on a Big Move in Surmodics Stock? - Nasdaq

May 02, 2025

May 01, 2025

SRDX Stock Down Following Q2 Earnings Miss, Gross Margin Contracts - TradingView

May 01, 2025

May 01, 2025

Surmodics Reports Q2 2025 Results Amid Acquisition Challenges - TipRanks

May 01, 2025

Apr 30, 2025

SurModics: Fiscal Q2 Earnings Snapshot - MySA

Apr 30, 2025

Apr 30, 2025

SurModics (SRDX) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance

Apr 30, 2025

Apr 30, 2025

SurModics stock touches 52-week low at $26.21 amid market shifts - Investing.com

Apr 30, 2025

Apr 30, 2025

Surmodics (SRDX) Projects Declining Revenue for Fiscal 2025 | SR - GuruFocus

Apr 30, 2025

Apr 30, 2025

Surmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial Guidance - BioSpace

Apr 30, 2025

Apr 30, 2025

Surmodics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

Apr 30, 2025

Apr 30, 2025

SurModics (SRDX) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance

Apr 30, 2025

Apr 30, 2025

Surmodics (SRDX) Reports Lower Than Expected Q2 Revenue Amid Ant - GuruFocus

Apr 30, 2025

Apr 30, 2025

Surmodics Reports Second Quarter of Fiscal Year 2025 Financial R - GuruFocus

Apr 30, 2025

Apr 30, 2025

SURMODICS INC SEC 10-Q Report - TradingView

Apr 30, 2025

Apr 30, 2025

Surmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial Guidance | SRDX Stock News - GuruFocus

Apr 30, 2025

Apr 30, 2025

Surmodics Reports Second Quarter Fiscal 2025 Financial Results - TradingView

Apr 30, 2025

Apr 29, 2025

A Look at Surmodics's Upcoming Earnings Report - Nasdaq

Apr 29, 2025

Apr 29, 2025

How To Trade (SRDX) - news.stocktradersdaily.com

Apr 29, 2025

Apr 28, 2025

Surmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30 - 01net

Apr 28, 2025

Apr 28, 2025

Surmodics to Report Second Quarter of Fiscal 2025 Financial Resu - GuruFocus

Apr 28, 2025

Apr 26, 2025

FTC Expands Lawsuit Against GTCR Over Surmodics Acquisition - MSN

Apr 26, 2025

Apr 22, 2025

Surmodics' SurVeil DCB Matches IN.PACT Admiral In Efficacy With Lower Drug Dose In Global Trial - Nasdaq

Apr 22, 2025

Apr 22, 2025

Surmodics (SRDX) Publishes Promising Clinical Trial Results for SurVeil DCB | SRDX Stock News - GuruFocus

Apr 22, 2025

Apr 22, 2025

Surmodics Announces Publication of TRANSCEND Trial, Highlighting - GuruFocus

Apr 22, 2025

Apr 22, 2025

Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated Balloon - Business Wire

Apr 22, 2025

Apr 22, 2025

Geode Capital Management LLC Sells 2,639 Shares of Surmodics, Inc. (NASDAQ:SRDX) - Defense World

Apr 22, 2025

Apr 18, 2025

Illinois, Minnesota join FTC challenge against $627M Surmodics buyout - MedTech Dive

Apr 18, 2025

Apr 18, 2025

Minnesota AG Ellison joins federal lawsuit to stop merger of companies that make medical device coatings - KIMT

Apr 18, 2025

Apr 17, 2025

Illinois joins FTC suit to block GTCR’s takeover of Surmodics - Crain's Chicago Business

Apr 17, 2025

Apr 17, 2025

AG Ellison Joins Suit to Block Surmodics Acquisition - Twin Cities Business

Apr 17, 2025

Apr 12, 2025

Corebridge Financial Inc. Lowers Stock Position in Surmodics, Inc. (NASDAQ:SRDX) - Defense World

Apr 12, 2025

Apr 08, 2025

(SRDX) Long Term Investment Analysis - news.stocktradersdaily.com

Apr 08, 2025

Apr 07, 2025

Surmodics Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm - ACCESS Newswire

Apr 07, 2025

Apr 04, 2025

SRDX Stock Dips Despite the Launch of Pounce XL Thrombectomy System - Yahoo Finance

Apr 04, 2025

Apr 03, 2025

Surmodics launches Pounce XL for peripheral artery clot removal By Investing.com - Investing.com South Africa

Apr 03, 2025

Apr 03, 2025

Surmodics launches Pounce XL thrombectomy system - Yahoo Finance

Apr 03, 2025

Apr 03, 2025

Surmodics launches Pounce XL for peripheral artery clot removal - Investing.com Australia

Apr 03, 2025

Apr 03, 2025

Revolutionary Blood Clot Treatment: Pounce XL Shows 80% Success Rate in Just 20 Minutes - Stock Titan

Apr 03, 2025

Mar 29, 2025

Gardner Lewis Asset Management L P Raises Position in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat

Mar 29, 2025

Mar 29, 2025

Learn to Evaluate (SRDX) using the Charts - news.stocktradersdaily.com

Mar 29, 2025

Mar 28, 2025

PE Firm Hits Back Against Medical Device Coating Challenge - Law360

Mar 28, 2025

Mar 25, 2025

FTC Challenges Medical Device Coatings Deal - Medical Product Outsourcing

Mar 25, 2025

Mar 24, 2025

Zacks Research Decreases Earnings Estimates for Surmodics - Defense World

Mar 24, 2025

Mar 23, 2025

Bank of New York Mellon Corp Sells 2,966 Shares of Surmodics, Inc. (NASDAQ:SRDX) - Defense World

Mar 23, 2025

Mar 18, 2025

Here's Why You Should Retain Surmodics Stock in Your Portfolio Now - Zacks Investment Research

Mar 18, 2025

Mar 13, 2025

FTC’s First Merger Challenge Under New Leadership Signals Return to Traditional Antitrust Theories in Private Equity Deals - JD Supra

Mar 13, 2025

Mar 12, 2025

GTCR / Surmodics: Four Key Takeaways for M&A Antitrust from the First FTC Merger Challenge Under Trump - JD Supra

Mar 12, 2025

Mar 10, 2025

FTC sues to block GTCR’s ‘unlawful acquisition’ of Surmodics - Yahoo Finance

Mar 10, 2025

Mar 10, 2025

Medical Coating Market Projected To Witness Substantial Growth, 2025-2032: Freudenberg Medical Europe GmbH, - EIN News

Mar 10, 2025

Mar 10, 2025

FTC Fights to Block Merger Threatening Healthcare Innovation and Patient-Critical Devices - MyChesCo

Mar 10, 2025